SCI Abstract

search
+
Perceptions and Attitudes Toward Oral Semaglutide Among Japanese Physicians and Individuals with Type 2 Diabetes: A Web-Based Survey
Perceptions and Attitudes Toward Oral Semaglutide Among Japanese Physicians and Individuals with Type 2 Diabetes: A Web-Based Survey
The oral formulation of the glucagon-like peptide-1 receptor agonist semaglutide has dosing requirements that could impact...
Insights on Hospitalisations from the Phase 3a ONWARDS 1–6 Trials of Once-Weekly Insulin Icodec
Insights on Hospitalisations from the Phase 3a ONWARDS 1–6 Trials of Once-Weekly Insulin Icodec
The ONWARDS programme assessed the efficacy and safety of once-weekly insulin icodec (icodec) versus once-daily basal insu...
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease
People with chronic kidney disease (CKD) and type 2 diabetes (T2D) have an increased risk of kidney failure and cardiovasc...
Continuous Glucose Monitoring Among People with and without Diabetes Mellitus and Sleep Apnoea
Continuous Glucose Monitoring Among People with and without Diabetes Mellitus and Sleep Apnoea
The association of sleep apnoea with insulin resistance and type 2 diabetes mellitus (T2DM) is well studied. However, litt...
Association Between Baseline Diabetes Therapy-Related Quality of Life (DTR-QOL) and Subsequent Risk of All-Cause Mortality: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 26])
Association Between Baseline Diabetes Therapy-Related Quality of Life (DTR-QOL) and Subsequent Risk of All-Cause Mortality: A Prospective Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 26])
We aimed to examine a cohort of people with diabetes to prospectively determine the association between diabetes therapy-r...
Type 2 Diabetes Mellitus Remission, Dream or Reality? A Narrative Review of Current Evidence and Integrated Care Strategies
Type 2 Diabetes Mellitus Remission, Dream or Reality? A Narrative Review of Current Evidence and Integrated Care Strategies
Type 2 diabetes mellitus (T2DM) is a global health priority, with an estimated 629 million people projec...
The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes Mellitus
The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes Mellitus
Insulin resistance (IR) is a major feature of type 2 diabetes mellitus (T2DM) and plays a crucial role in the accelerated ...
Time Trends of Body Mass Index and its Impact on Glycemic Control Among Finnish Patients with Type 2 Diabetes
Time Trends of Body Mass Index and its Impact on Glycemic Control Among Finnish Patients with Type 2 Diabetes
Obesity prevalence has increased in Finland and is prevalent in patients with type 2 diabetes (T2D). Also, hyperg...
Evaluating the Impact of mySugr Mobile Health Application on Glycemic Control in People with Diabetes Mellitus in India: A Real-World Data Analysis
Evaluating the Impact of mySugr Mobile Health Application on Glycemic Control in People with Diabetes Mellitus in India: A Real-World Data Analysis
The rising prevalence of diabetes has driven extensive research into effective management strategies, emphasizing the impo...
The Clock is Still Ticking: Tirzepatide and the Myth of Halting the Natural History of Type 2 Diabetes
The Clock is Still Ticking: Tirzepatide and the Myth of Halting the Natural History of Type 2 Diabetes
Prediabetes is a growing global health concern. In 2021, the global prevalence of impaired glucose tolerance (IGT) among a...
Safety and Efficacy of Inhaled Technosphere Insulin in the Postprandial Period With Modified Initial Dose Conversion
Safety and Efficacy of Inhaled Technosphere Insulin in the Postprandial Period With Modified Initial Dose Conversion
A post hoc analysis from a 90-day proof-of-concept study demonstrated increased efficacy and no new safety concerns for an...
Correction: Effcacy of Polyethylene Glycol Loxenatide in Combination with Basal Insulin in Patients with Type 2 Diabetes Mellitus: A Retrospective Real-World Study
Correction: Effcacy of Polyethylene Glycol Loxenatide in Combination with Basal Insulin in Patients with Type 2 Diabetes Mellitus: A Retrospective Real-World Study
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Perceptions of Suboptimal Insulin Dosing from People with Diabetes and Healthcare Professionals in Germany
Perceptions of Suboptimal Insulin Dosing from People with Diabetes and Healthcare Professionals in Germany
Despite advancements in diabetes therapeutics and innovations, suboptimal dosing continues to be a barrier to glycaemic co...
Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
The increasing prevalence of type 2 diabetes (T2D) can be considered a global healthcare emergency, with far-reac...
Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes
Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes
Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with diabetes mellitus, representin...
Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical Laboratory-Led Quality Improvement Initiative in General Practice
Improving Diabetes Monitoring in People with Sub-optimally Controlled Diabetes: Implementing a Clinical Laboratory-Led Quality Improvement Initiative in General Practice
The appropriate use of glycated haemoglobin (HbA1c), the international standard for assessing overall glycaemic status in ...
Correction to: Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study
Correction to: Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study
Correction: Diabetes Ther (2025) 16:121–134 https://doi.org/10.1007/s13300-024-01670-...
Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes
Treatment Patterns and Glycaemic Control Between 2015 and 2019 in Tianjin, China: A Real-World Study of Adults with Type 2 Diabetes
Diabetes is associated with a high economic burden in China; therefore, strategies to prevent diabetes, improve glycaemic ...
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
The high risk of cardiovascular events in people with type 2 diabetes increases with age. The cardiovascular effe...
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics
Newer incretin-based therapies for type 2 diabetes (T2D) have the potential to substantially reduce glycated hemo...
Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
Oral semaglutide is a glucagon-like peptide 1 receptor agonist (GLP-1RA) approved for improving glycemic control ...
Risk Evaluation of Progression of Proteinuria and Renal Decline Based on a Novel Subgroup Classification in Chinese Patients with Type 2 Diabetes
Risk Evaluation of Progression of Proteinuria and Renal Decline Based on a Novel Subgroup Classification in Chinese Patients with Type 2 Diabetes
Type 2 diabetes mellitus (T2DM) is a highly heterogeneous disease with a varying risk of complications. The recent novel s...
The Impact of Comorbid Dementia and Diabetes Mellitus on Hospital Patients’ Outcomes: A Systematic Review and Meta-analysis
The Impact of Comorbid Dementia and Diabetes Mellitus on Hospital Patients’ Outcomes: A Systematic Review and Meta-analysis
Previous reviews have demonstrated that dementia and diabetes mellitus, separately, can worsen the hospital outcomes of pa...
12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes
12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes
Time in tight range (TITR) is an emerging and valuable metric for assessing normoglycemia. The latest advancement in autom...
Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
When switching from premixed insulin to insulin degludec/aspart (IDegAsp), IDegAsp usually starts at the same dose as the ...
Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data
Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data
Since the introduction of insulin therapy, it has become apparent that type 1 diabetes (T1D) is accompanied by long-term m...
Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan
Burden of Current Insulin Therapy and Expectations for Future Insulin Therapy: Results from INBEING, a Web-Based Survey in Japan
This survey assessed the perspectives of physicians, people with diabetes (PWD), and caregivers in Japan regarding initiat...
The Efficacy and Safety of Liraglutide in Patients Remaining Obese 6 Months after Metabolic Surgery
The Efficacy and Safety of Liraglutide in Patients Remaining Obese 6 Months after Metabolic Surgery
The safety and efficacy of liraglutide as a weight loss intervention in individuals who remain obese within 1 yea...
Sodium-Glucose Co-transporter-2 Inhibitors in Type 1 Diabetes Mellitus: The Framework for Recommendations for Their Potential Use
Sodium-Glucose Co-transporter-2 Inhibitors in Type 1 Diabetes Mellitus: The Framework for Recommendations for Their Potential Use
The growing prevalence of overweight/obesity, the persistence of inadequate glycemic control among the majority o...
Rationale and Design of the Study to Investigate the Metabolic Action of Imeglimin on Patients with Type 2 Diabetes Mellitus (SISIMAI)
Rationale and Design of the Study to Investigate the Metabolic Action of Imeglimin on Patients with Type 2 Diabetes Mellitus (SISIMAI)
Imeglimin is a first-in-class, novel, oral glucose-lowering agent for the treatment of type 2 diabetes mellitus. ...
Load More
format_indent_increase